Response Genetics names Bologna CEO

Cancer diagnostic company Response Genetics Inc. (NASDAQ:RGDX) hired Thomas Bologna as chairman and CEO. He succeeds Kirk Calhoun as chairman and replaces interim CEO Denise McNairn. Calhoun will rema...